Company Profile

NanoXort LLC
Profile last edited on: 1/15/24      CAGE: 86NR2      UEI: XEFGPVQ94B79

Business Identifier: MRI imaging contrast agent solution
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

540 Devall Drive Suite 101-1a02
Auburn, AL 36832
   (646) 258-9152
Location: Single
Congr. District: 03
County: Lee

Public Profile

Spun out of research conducted at Georgia Tech and at Auburn University, Nanoxort develops MRI contrast agents. The firm's contrast agents allow physicians to make more accurate disease diagnoses and provide patients with more personalized and effective treatments. The contact agents produce brighter images for more accurate readings, where contrast agents are used in roughly one-third of MRI procedures to help improve the accuracy for conditions such as inflammatory and infectious diseases. The firm's solution reduces the toxicity of MRI contrast agents and enables fine control of the properties of magnetic nano materials.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NSF $1,255,676
Project Title: Novel Size-Changing, Gadolinium-Free Contrast Agent for Magnetic Resonance Angiography

Key People / Management

  Tareq Anani -- President and Co-founder

  Allan David -- Co-Founder

  Abhinav Sannidhi -- R&D Manager / Principal Investigator

  Barry Yeh -- Co-founder / General Manager